… Our aim was therefore to distribute a follow-up international survey in electronic format to
elucidate an overview on the current stage of implementation, acceptance and challenges of …

… In this context, we designed a study to assess … of pharmacogenomics implementation in
clinical practice. Further, we also aimed to assess the effects of experience years, practice setting…

… Monitoring and Clinical Toxicology (IATDMCT) have also recently initiated surveys in order
to better understand the extent of, and the role played by, PGx testing in clinical practice. This …

… study on the pharmacogenetics of cardiovascular drugs, only a small percentage of the
patients (1.1%) did not want to participate in the study … pharmacogenetics into clinical practice. …

… that we are moving toward the clinical use of pharmacogenetics, as predicted by Francis
Collins, … For example, recent surveys of practicing physicians indicate a majority are aware of …

… Pharmacogenetics is the study of genetic differences between individuals that contribute to
the efficacy and safety of drugs, identifying patients with a decreased likelihood of response …

… to conduct a large-scale pharmacogenetic study in Ontario, in … CYP2C19 genetic testing in
clinical practice and to determine … Our experiences in our Pharmacogenetics Research Clinic (…

… The European EU-PACT study confirmed that the use of pharmacogenetics in individual
dosing shortened the time needed to reach the therapeutic INR by 8 days and more subjects …

… of PGx, its incorporation into the clinic has been frustratingly slow, and so far it … medical
professionals agree on the importance of PGx in clinical practice, but that they are reluctant to use …

… These data can help identify potential challenges of translating PGx testing into clinical
practice as well as suggest professional roles and guidelines to support clinical use of PGx testing…